Objective To assess the relationship between functional mitral regurgitation (MR) after a non-ST segment elevation acute coronary syndrome (NSTSEACS) and long-term prognosis, ventricular remodelling and further development of atrial fibrillation (AF), since functional MR is common after myocardial infarction. Design and setting Prospective cohort study conducted in a tertiary referral centre. Patients We prospectively studied 237 patients consecutively discharged in New York Heart Association class I-II (74% men; mean age 66.1 years) after a first NSTSEACS. All underwent an ECG the first week after admission and were echocardiographically and clinically followed-up (median 6.95 years). Results MR was detected in 95 cases (40.1%) and became an independent risk factor for the development of heart failure (HF) and major adverse cardiovascular events (MACE) ( per MR degree, HR HF 1.71, 95% CI
INTRODUCTION
Ischaemic mitral regurgitation (MR) is common after a myocardial infarction. It has been deemed to be a predictor of long-term cardiac mortality and morbidity after either a Q-wave acute myocardial infarction (AMI) or a non-ST segment elevation acute coronary syndrome (NSTSEACS). [1] [2] [3] [4] [5] [6] [7] The mechanism linking MR and outcome is only partially understood. 7 8 Beeri et al 9 have described the role of moderate ischaemic MR in the development of left ventricle (LV) remodelling after a myocardial infarction. However, data on the influence of functional MR on LV dilation after an NSTSEACS are scarce. 8 LV enlargement related to the development of functional MR may be one of the main links between the two entities. In addition, atrial fibrillation (AF) seems to be the most common cardiac arrhythmia seen in clinical practice. 10 AF has also been reported as a common complication after an AMI with an incidence ranging between 5% and 23%. 11 12 Based on the latter, an association of AF with short-and long-term mortality among patients with ST segment elevation acute coronary syndrome (STSEACS) and NSTSEACS has been postulated. 13 Our objective was to assess the contemporary long-term prognosis and the relationship between the presence and severity of functional MR after an NSTSEACS episode, and the development of LV enlargement and AF.
METHODS

Between November 2003 and September 2005, 311
consecutive patients were admitted for a first NSTSEACS episode. Patients with previous NSTSEACS, hypertrophic cardiomyopathy, mitral valve/subvalvular apparatus structural disease and acute mechanical post-infarction complications were not included. Twenty patients from the study group died during hospitalisation. The 237 remaining patients were discharged from hospital in New York Heart Association functional class I-II and constituted the study group. Thirty-three died during follow-up before the interim control echocardiogram. The diagnosis of NSTSEACS was based on the European Society of Cardiology criteria. All patients were prospectively selected and followed-up.
Before discharge, all patients underwent a complete transthoracic echocardiogram, in which mitral valve anatomy and function were specifically studied during a median (IQR) of 2 (1-3) days after admission. It was performed using a Philips Sonos 5500 with 2.5-3.5 MHz probes. Patients with structural disease of the mitral valve and/ or subvalvular apparatus were excluded from the cohort, in order to study only those with a clear functional cause of MR. The presence and degree of MR was evaluated using the proximal isovelocity surface area method and a validated nomogram for semiquantitative estimation.
14 Left atrial and ventricular diameters were measured in the parasternal view on M mode. The ejection fraction was calculated in two-dimensional mode, in the two-and four-chamber apical views, using the Simpson biplane method. Myocardial thickening was assessed by dividing the LV up as in the 16-segment model, following the recommendations of the American Society of Echocardiography.
Cardiac catheterisation was performed according to the attending physician's preferences. The extent of coronary artery disease was characterised by the traditional diameter stenosis percentage and one-, two-or three-vessel disease classification.
After discharge, all patients were followed-up in the outpatient clinic or by telephone interview. A control echocardiogram was performed at least 1 year after the first NSTSEACS episode. Each event was recorded only once; for example, after a heart failure event, new episodes were not taken into account in the statistical analysis of major adverse cardiovascular events (MACE) (heart failure/angina-infarction/all-cause death). For all variables, the patient data were censored after the first event. Three sets of data are provided named the clinical, structural (remodelling) and rhythm arms. For the clinical arm, the full follow-up is considered. For the structural and rhythm arms, only the interim follow-up is considered (median follow-up 1126 days). Patients who were subsequently lost, died or had baseline AF were excluded from the rhythm analysis at the outset to avoid the loss of statistical power caused by the decrease in sample size secondary to lost or deceased patients years later.
Statistical analysis
The SPSS V. 15 as indicated by the dispersion of data. MR was classified as a dichotomous or categorical variable, depending on the analysis. To evaluate the reliability of the MR-grading method used in our laboratory and reported in this paper, intraobserver concordance (Iván J Núñez Gil) and between-observer concordance (Iván J Núñez Gil and Leopoldo Pérez de Isla) were calculated in 30 studies using the κ index. Thus, intraobserver (κ=0.91) and interobserver (κ=0.84) concordance were excellent. Long-term survival curves for the different groups were obtained using the Kaplan-Meier method, and comparisons were made using the log-rank test. The Cox proportional hazard regression model was used to analyse and select variables that were independently associated with the appearance of longterm events. An excessive number of variables in the multivariate analysis was avoided by reducing the number by using a prespecified model that included those known to be associated with prognosis and regarding the univariate findings. Thus, age (quantitative), diabetes mellitus and hypertension ( present in discharge reports), kidney failure (creatinine clearance <60 mL/ h according to the Cockroft-Gault formula), LV ejection fraction (LVEF), peak troponin level (quantitative), previous revascularisation, current multivessel disease (two or more vessels), AF, ventricular wall motion abnormalities ( present) and MR (qualitative and quantitative) were included as covariates in the final models, and several clinical events were included as dependent variables. HR and 95% CI were calculated by backward stepwise regression analysis (Wald).
The last follow-up was conducted on 1 December 2012. The null hypothesis was rejected using a two-tailed p value <0.05 as cut-off.
RESULTS
Baseline characteristics
The mean age of the 237 patients studied was 66.1±12.9 years (29-91), and 175 (73.8%) were men. The incidence of MR was 40.1% (95 patients; 73 men). The distribution of the severity of MR, assessed on the first ECG, was: 71 patients degree I (30.0%), 15 degree II (6.3%), six degree III (2.5%) and three degree IV (1.26%). Epidemiological features and differences are depicted in table 1. On ECG, there were no differences in Q-wave development, the presence of a transient ST-segment elevation (<20 min), and the location of changes in repolarisation. However, a marked ST-segment depression was more common in the MR group. Medical therapies in patients with/ without MR at the time of discharge showed no differences between the two groups (ACE inhibitors/angiotensin II receptor blocker (ARBs), β-blockers, calcium channel blockers, nitrates, diuretics, spironolactone; p>0.10). No patients in this study had the mitral valve repaired either because they had no indications for this procedure or because of the presence of contraindications or patient preference.
Coronary anatomy
A total of 212 patients (89.5%) underwent coronary angiography during the index hospitalisation. The results are displayed in table 1. The difference in the number of patients revascularised in each group did not reach significance.
Events and long-term follow-up
Patients were followed-up for a median of 2540 days (IQR 856-2843); there were no significant differences between groups ( p=0.391). Admissions for unstable angina, heart failure or the combined event (MACE) were all more common in the MR group. Follow-up events are displayed in table 2 and figure 1.
Survival curves show that the development of MACE (figure 1A,B) and heart failure (figure 1C) depended on the presence or absence of MR and on its severity. Univariate analysis for MACE is provided in table 3. Cox regression multivariate analysis revealed age, diabetes mellitus, hypertension, previous revascularisation and the presence of functional MR to be relevant to the development of heart failure and MACE. However, only diabetes mellitus and MR were found to be independent predictors in the final multivariate analysis. The most relevant results in the multivariate analysis are shown in table 4.
Remodelling arm
A total of 153 patients were finally included in the structural analysis. Their epidemiological features were similar to those in the overall group. As shown in table 5, at baseline, LV endsystolic diameters were significantly greater, LV performance was diminished, the prevalence of LV wall motion abnormalities in the echocardiographic study was higher, and the left atrium diameter was larger in the patients with MR. No differences were found in volumes between groups at this stage.
After a similar follow-up (1108 days, IQR 995-1234), left atrial, LV end-diastolic and LV end-systolic diameters continued to be higher in the MR group compared with the group without MR. However, at that point, LV end-diastolic volume (LVEDV) and LV end-systolic volume (LVESV) were higher in the MR group (table 5) .
In addition, comparing the MR group evolution adjusted by degree of MR, we observed a significant proportional LV dilatation, with regard to mean LVEDV ( figure 2A ) and mean LVESV (figure 2B). 
Rhythm arm
The number of patients included in this study group was 126. Baseline characteristics and discharge drugs were also similar to the overall cohort. The difference in the number of patients revascularised in each group did not reach significance. Patients were followed-up for rhythm for a median of 1126 days. During this follow-up period, no patients died ( previously excluded). Admissions for AMI, unstable angina and heart failure were all more common in the MR group (table 2) . Baseline LV end-systolic and diastolic diameters were significantly greater ( p=0.005, p=0.001, respectively), LV performance was diminished (LVEF 59.3±16.8% vs 51.5±15.0%, p=0.012), the prevalence of LV wall motion abnormalities in the echocardiographic study was higher (41.8% vs 61.7%, p=0.03), and the left atrial diameter was slightly larger (37.9 ±5.4 vs 42.0±8.0 mm) in the group of patients with MR.
AF was significantly more common in the MR group (19.2% vs 3.8%, p=0.009; figure 3A ). In addition, comparing the MR group evolution adjusted by MR degree, we observed a statistically significant proportional AF development. Interestingly, AF appeared in 5.1% of patients with MR degree 0, 11.4% with MR degree 1, 14.3% with MR degree 2, and 75% with MR degree 3 ( p<0.001) (figure 3B).
DISCUSSION
To our knowledge, this study is the first to assess the very-long-term prognostic implications of the development of MR after a first NSTSEACS. In addition, it is the first study to specifically address the relationship between MR and long-term structural and rhythm outcomes, establishing interesting relationships.
Ischaemic or functional MR occurs with a structurally preserved mitral valve as a result of an altered force balance on the leaflets. Causal mechanisms comprise annulus dilatation, ischaemia or a scar at the level of the papillary muscles, papillary muscle rupture, and most commonly, a change in the ventricular geometry causing tethering of the mitral leaflets. In addition, systolic dysfunction has been considered to be another factor that contributes to MR caused by restricted movement of the leaflets. 1 4-7 14-23 However, all the circumstances surrounding the development of ischaemic MR are still not well clarified.
In this study, larger LV systolic size, together with lower LVEF and segmental wall motion abnormalities, were more common in patients with functional MR. This suggests an effect of extensive coronary artery disease on the degree of cardiomyopathy in our patients and it is probably the factor most closely related to the development of functional MR.
Of note, although the development of ischaemic MR was associated with a worse long-term outcome, it did not show a clear worse in-hospital outcome in our series (excluding previously unstable patients or mechanical complications). This finding is logical, since progressive LV remodelling takes time to develop and the in-hospital stay is quite short.
As the protocol was not designed to evaluate this point, an alternative analysis was performed on patients with LVEF ≥ or <45%. The results for those with LVEF ≥45% were similar to those in patients with preserved systolic function ( per MR degree, HR MACE 1.5, 95% CI 1.096 to 2.095, p=0.012), but with a lack of statistical significance in the cohort with depressed LVEF. These findings should be considered with caution because of the small numbers enrolled in each group. 
Remodelling arm
Beeri et al 9 described the role of moderate ischaemic MR in the development of LV enlargement in a sheep controlled model, which created a standardised moderate MR-like regurgitant flow and a provoked anteroapical infarction, which by itself does not cause MR. Moderate MR was shown to worsen post-AMI remodelling, with reduced contractility, independently of the accompanying infarction.
Furthermore, our results in humans also show that a greater severity of functional MR is associated with greater remodelling after long-term follow-up. Our patients with MR developed more complications than patients without MR, in spite of previous selection to exclude patients who died before the control ECG, as previously published elsewhere. 5 7 8 16 Therefore, identification of factors related to a bad prognosis in patients in an adequate functional class at the time of hospital discharge after the acute coronary syndrome is very important in order to optimise their therapeutic management. 24 De Bonis et al 25 found that, in patients with an effective repair of the functional MR, a better clinical outcome is associated with reverse LV remodelling compared with patients with persistence, or progression, of the remodelling process.
MR, caused by alterations in LV architecture and function after infarction, can itself initiate the remodelling process. It alters the load on the LV. It increases diastolic wall stress, which can induce eccentric LV hypertrophy and subsequent dilatation and failure. 8 Therefore, MR may represent both a cause and a result of LV remodelling. The contribution of MR to LV remodelling was previously assessed by a study using a posterolateral infarction sheep model in which either MR was treated using an undersized prosthetic annuloplasty ring or the myocardium was restrained with a mesh. The MR group showed greater remodelling, and the authors concluded that MR is not a cause of postinfarction remodelling. 26 These results were later questioned because of the theoretically proper deleterious effects of undersized rings. 8 This LV remodelling, which seems to be related to the degree of MR, may partly explain the worse prognosis for the MR group compared with the cohort without MR, as even low degrees of MR can result in LV enlargement and promote the development of heart failure and arrhythmias.
Rhythm arm
AF is a common arrhythmia 10 which has often been linked to increased left atrium diameters predicting risk of cardiovascular events. 27 Furthermore, AF is a common finding in both STSEACS and NSTSEACS. 12 13 28 A large meta-analysis by Lopes et al, 13 including more than 100 000 patients in 10 large clinical trials, reported that AF is independently associated with worse outcomes across the spectrum of acute coronary syndrome (both STSEACS and NSTSEACS), and is a predictor of increased short-and long-term mortality. Unfortunately, the presence of MR was not assessed by the latter study. In fact, clinical factors related to ischaemic cardiomyopathy and MR, 5 7 such as age, heart failure and infarction, were correctly reported to be predictors of non-valvular AF a long time ago by the SPAF investigators. 29 Their data also showed that an enlarged left atrium was associated with recurrent intermittent AF, and an enlarged left ventricle predicted conversion to constant AF. Thus, clinical and echocardiographic variables predicted AF in patients with non-valvular AF. 27 29 The results of the present work agree with their data. We observed larger cavities in the MR cohort, lower LVEF, more adverse outcomes and a higher percentage of patients with AF with regard to the initial degree of MR. MR, caused by alterations in LV architecture and function after infarction, can itself stimulate AF. Thus, MR may represent the missing link between these two approaches, explaining in part the adverse outcomes related to MR degree in NSTSEACS. Again, MR may represent both a cause and a result of AF.
Clinical implications
In brief, as previously discussed, we feel that the presence of MR, even in mild degrees, must be carefully considered as a marker of a risk of a bad prognosis, from the standpoint of both heart failure and AF development. Since, in isolation, the haemodynamic relevance of minor degrees of MR is probably trivial, one should pay attention to the cardiomyopathy itself. Thus, we consider that any degree of MR warrants careful monitoring, with strict compliance with the treatments recommended by the guidelines for secondary prevention.
Limitations
We cannot be sure that, in the patients included in our study, any degree of MR was present before the index event, since we cannot distinguish between pre-existing MR and new-onset MR. Pre-AMI MR is a well-described prognostic factor. 4 In previous studies analysing prognosis after a Q-wave myocardial infarction, the presence of pre-AMI MR was not analysed either. However, we feel that this limitation is only minor if we consider previously published papers. With regard to the high prevalence of MR, many factors are probably involved in its development, but it would be difficult to reach any definitive conclusion about what they are because it would be necessary to have a group of patients with Q-wave AMI for comparison to obtain any concrete conclusions.
Not all patients in our series underwent a cardiac catheterisation procedure, but it is of note that this study is not an intervention study. Thus, the management of our patients was the standard in our hospital at that time and depended on the attending physician. So, we think our results come close to real life clinical practice.
Conclusions
MR is common after an NSTSEACS. The presence and degree of MR confers a worse long-term prognosis on patients after a first NSTSEACS. This can in part be explained by increased negative remodelling and increased occurrence of AF. Thus, the degree of MR should be carefully appraised in all patients after an NSTSEACS.
